 Serotonin 5-HT2 Receptor Agonists
"Serotonin 5-HT2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.
| Descriptor ID |
D058826
|
| MeSH Number(s) |
D27.505.519.625.850.800.200 D27.505.696.577.850.800.200
|
| Concept/Terms |
Serotonin 5-HT2 Receptor Agonists- Serotonin 5-HT2 Receptor Agonists
- Serotonin 5 HT2 Receptor Agonists
- 5-HT2 Agonists
- 5 HT2 Agonists
- Agonists, 5-HT2
- 5-HT2 Agonist
- 5 HT2 Agonist
- Agonist, 5-HT2
|
Below are MeSH descriptors whose meaning is more general than "Serotonin 5-HT2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Serotonin 5-HT2 Receptor Agonists".
This graph shows the total number of publications written about "Serotonin 5-HT2 Receptor Agonists" by people in this website by year, and whether "Serotonin 5-HT2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 2 | 2 | | 2019 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Serotonin 5-HT2 Receptor Agonists" by people in Profiles.
-
Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc Natl Acad Sci U S A. 2021 04 27; 118(17).
-
Jin B, Ha SE, Wei L, Singh R, Zogg H, Clemmensen B, Heredia DJ, Gould TW, Sanders KM, Ro S. Colonic Motility Is Improved by the Activation of 5-HT2B Receptors on Interstitial Cells of Cajal in Diabetic Mice. Gastroenterology. 2021 08; 161(2):608-622.e7.
-
Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. Circulation. 2019 01 15; 139(3):366-375.
-
Tye H, Mueller SG, Prestle J, Scheuerer S, Schindler M, Nosse B, Prevost N, Brown CJ, Heifetz A, Moeller C, Pedret-Dunn A, Whittaker M. Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders. Bioorg Med Chem Lett. 2011 Jan 01; 21(1):34-7.
-
Strong PV, Greenwood BN, Fleshner M. The effects of the selective 5-HT(2C) receptor antagonist SB 242084 on learned helplessness in male Fischer 344 rats. Psychopharmacology (Berl). 2009 May; 203(4):665-75.
-
Hawkins MF, Uzelac SM, Hearn JK, Baumeister AA. Effects of selective serotonin2 ligands on behaviors evoked by stress in the rat. Pharmacol Biochem Behav. 2008 Oct; 90(4):632-9.
-
Greenwood BN, Strong PV, Brooks L, Fleshner M. Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise. Psychopharmacology (Berl). 2008 Aug; 199(2):209-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|